MEITHEAL Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MEITHEAL, and what generic and branded alternatives to MEITHEAL drugs are available?
MEITHEAL has seventy-eight approved drugs.
Drugs and US Patents for MEITHEAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Meitheal | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 217348-001 | Jan 11, 2024 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Meitheal | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride | POWDER;INTRAVENOUS | 211001-001 | Jun 5, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Meitheal | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 205030-001 | Apr 20, 2018 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for MEITHEAL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
Similar Applicant Names
Here is a list of applicants with similar names.